Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0005845 | mRNA cap binding complex | 3 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0034518 | RNA cap binding complex | 2 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
GO:0140535 | intracellular protein-containing complex | 2 | 2 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: Q4Q266
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006370 | 7-methylguanosine mRNA capping | 8 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006397 | mRNA processing | 7 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009452 | 7-methylguanosine RNA capping | 8 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0016071 | mRNA metabolic process | 6 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0036260 | RNA capping | 7 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity | 6 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0008168 | methyltransferase activity | 4 | 12 |
GO:0008170 | N-methyltransferase activity | 5 | 12 |
GO:0008173 | RNA methyltransferase activity | 4 | 12 |
GO:0008174 | mRNA methyltransferase activity | 5 | 12 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 5 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 113 | 115 | PF00675 | 0.261 |
CLV_NRD_NRD_1 | 14 | 16 | PF00675 | 0.381 |
CLV_PCSK_KEX2_1 | 113 | 115 | PF00082 | 0.236 |
CLV_PCSK_KEX2_1 | 123 | 125 | PF00082 | 0.237 |
CLV_PCSK_KEX2_1 | 16 | 18 | PF00082 | 0.236 |
CLV_PCSK_KEX2_1 | 204 | 206 | PF00082 | 0.307 |
CLV_PCSK_PC1ET2_1 | 123 | 125 | PF00082 | 0.235 |
CLV_PCSK_PC1ET2_1 | 16 | 18 | PF00082 | 0.258 |
CLV_PCSK_PC1ET2_1 | 204 | 206 | PF00082 | 0.307 |
CLV_PCSK_SKI1_1 | 176 | 180 | PF00082 | 0.293 |
CLV_PCSK_SKI1_1 | 36 | 40 | PF00082 | 0.404 |
CLV_PCSK_SKI1_1 | 74 | 78 | PF00082 | 0.205 |
DEG_ODPH_VHL_1 | 186 | 199 | PF01847 | 0.234 |
DOC_CYCLIN_RxL_1 | 166 | 177 | PF00134 | 0.220 |
DOC_CYCLIN_RxL_1 | 309 | 319 | PF00134 | 0.312 |
DOC_MAPK_gen_1 | 36 | 42 | PF00069 | 0.301 |
DOC_MAPK_MEF2A_6 | 155 | 163 | PF00069 | 0.235 |
DOC_PP1_RVXF_1 | 310 | 317 | PF00149 | 0.270 |
DOC_PP2B_LxvP_1 | 86 | 89 | PF13499 | 0.148 |
DOC_PP4_FxxP_1 | 220 | 223 | PF00568 | 0.293 |
DOC_USP7_MATH_1 | 168 | 172 | PF00917 | 0.286 |
DOC_USP7_MATH_1 | 227 | 231 | PF00917 | 0.163 |
DOC_USP7_MATH_1 | 53 | 57 | PF00917 | 0.292 |
DOC_WW_Pin1_4 | 147 | 152 | PF00397 | 0.412 |
DOC_WW_Pin1_4 | 51 | 56 | PF00397 | 0.340 |
DOC_WW_Pin1_4 | 77 | 82 | PF00397 | 0.199 |
LIG_14-3-3_CanoR_1 | 155 | 159 | PF00244 | 0.205 |
LIG_14-3-3_CanoR_1 | 264 | 273 | PF00244 | 0.239 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.433 |
LIG_BRCT_BRCA1_1 | 149 | 153 | PF00533 | 0.245 |
LIG_BRCT_BRCA1_1 | 159 | 163 | PF00533 | 0.188 |
LIG_BRCT_BRCA1_1 | 216 | 220 | PF00533 | 0.302 |
LIG_BRCT_BRCA1_1 | 277 | 281 | PF00533 | 0.235 |
LIG_deltaCOP1_diTrp_1 | 19 | 28 | PF00928 | 0.355 |
LIG_EVH1_1 | 220 | 224 | PF00568 | 0.352 |
LIG_FHA_1 | 194 | 200 | PF00498 | 0.417 |
LIG_FHA_1 | 251 | 257 | PF00498 | 0.148 |
LIG_FHA_2 | 131 | 137 | PF00498 | 0.325 |
LIG_FHA_2 | 193 | 199 | PF00498 | 0.218 |
LIG_FHA_2 | 236 | 242 | PF00498 | 0.211 |
LIG_LIR_Apic_2 | 217 | 223 | PF02991 | 0.302 |
LIG_LIR_Apic_2 | 253 | 258 | PF02991 | 0.215 |
LIG_LIR_Gen_1 | 177 | 187 | PF02991 | 0.220 |
LIG_LIR_Gen_1 | 214 | 224 | PF02991 | 0.354 |
LIG_LIR_Gen_1 | 278 | 288 | PF02991 | 0.258 |
LIG_LIR_Nem_3 | 150 | 156 | PF02991 | 0.207 |
LIG_LIR_Nem_3 | 177 | 182 | PF02991 | 0.249 |
LIG_LIR_Nem_3 | 214 | 219 | PF02991 | 0.207 |
LIG_LIR_Nem_3 | 278 | 284 | PF02991 | 0.218 |
LIG_LIR_Nem_3 | 309 | 314 | PF02991 | 0.221 |
LIG_LIR_Nem_3 | 95 | 101 | PF02991 | 0.295 |
LIG_MLH1_MIPbox_1 | 216 | 220 | PF16413 | 0.235 |
LIG_PCNA_yPIPBox_3 | 36 | 48 | PF02747 | 0.234 |
LIG_PDZ_Class_2 | 318 | 323 | PF00595 | 0.325 |
LIG_Pex14_2 | 138 | 142 | PF04695 | 0.206 |
LIG_PTB_Apo_2 | 210 | 217 | PF02174 | 0.352 |
LIG_PTB_Phospho_1 | 210 | 216 | PF10480 | 0.352 |
LIG_SH2_CRK | 156 | 160 | PF00017 | 0.352 |
LIG_SH2_CRK | 311 | 315 | PF00017 | 0.245 |
LIG_SH2_NCK_1 | 10 | 14 | PF00017 | 0.349 |
LIG_SH2_NCK_1 | 156 | 160 | PF00017 | 0.234 |
LIG_SH2_NCK_1 | 226 | 230 | PF00017 | 0.191 |
LIG_SH2_PTP2 | 255 | 258 | PF00017 | 0.235 |
LIG_SH2_SRC | 10 | 13 | PF00017 | 0.352 |
LIG_SH2_STAP1 | 216 | 220 | PF00017 | 0.344 |
LIG_SH2_STAP1 | 288 | 292 | PF00017 | 0.321 |
LIG_SH2_STAT5 | 255 | 258 | PF00017 | 0.283 |
LIG_SH3_3 | 145 | 151 | PF00018 | 0.352 |
LIG_SH3_3 | 218 | 224 | PF00018 | 0.352 |
LIG_SUMO_SIM_anti_2 | 171 | 177 | PF11976 | 0.234 |
LIG_SUMO_SIM_anti_2 | 304 | 309 | PF11976 | 0.270 |
LIG_SUMO_SIM_par_1 | 190 | 196 | PF11976 | 0.352 |
LIG_SUMO_SIM_par_1 | 60 | 66 | PF11976 | 0.272 |
LIG_UBA3_1 | 118 | 123 | PF00899 | 0.163 |
LIG_WW_1 | 223 | 226 | PF00397 | 0.234 |
MOD_CK1_1 | 157 | 163 | PF00069 | 0.374 |
MOD_CK1_1 | 180 | 186 | PF00069 | 0.352 |
MOD_CK2_1 | 235 | 241 | PF00069 | 0.234 |
MOD_CK2_1 | 298 | 304 | PF00069 | 0.352 |
MOD_CK2_1 | 51 | 57 | PF00069 | 0.234 |
MOD_DYRK1A_RPxSP_1 | 51 | 55 | PF00069 | 0.148 |
MOD_GlcNHglycan | 179 | 182 | PF01048 | 0.352 |
MOD_GlcNHglycan | 287 | 291 | PF01048 | 0.427 |
MOD_GlcNHglycan | 65 | 68 | PF01048 | 0.280 |
MOD_GlcNHglycan | 89 | 92 | PF01048 | 0.194 |
MOD_GSK3_1 | 143 | 150 | PF00069 | 0.410 |
MOD_GSK3_1 | 275 | 282 | PF00069 | 0.356 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.199 |
MOD_NEK2_1 | 138 | 143 | PF00069 | 0.324 |
MOD_NEK2_1 | 235 | 240 | PF00069 | 0.324 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.353 |
MOD_PIKK_1 | 20 | 26 | PF00454 | 0.352 |
MOD_PIKK_1 | 298 | 304 | PF00454 | 0.239 |
MOD_PKA_2 | 143 | 149 | PF00069 | 0.419 |
MOD_PKA_2 | 154 | 160 | PF00069 | 0.205 |
MOD_PKA_2 | 275 | 281 | PF00069 | 0.148 |
MOD_Plk_4 | 138 | 144 | PF00069 | 0.373 |
MOD_Plk_4 | 154 | 160 | PF00069 | 0.215 |
MOD_Plk_4 | 214 | 220 | PF00069 | 0.148 |
MOD_Plk_4 | 306 | 312 | PF00069 | 0.229 |
MOD_Plk_4 | 93 | 99 | PF00069 | 0.288 |
MOD_ProDKin_1 | 147 | 153 | PF00069 | 0.412 |
MOD_ProDKin_1 | 51 | 57 | PF00069 | 0.340 |
MOD_ProDKin_1 | 77 | 83 | PF00069 | 0.199 |
TRG_ENDOCYTIC_2 | 10 | 13 | PF00928 | 0.323 |
TRG_ENDOCYTIC_2 | 156 | 159 | PF00928 | 0.300 |
TRG_ENDOCYTIC_2 | 216 | 219 | PF00928 | 0.277 |
TRG_ENDOCYTIC_2 | 311 | 314 | PF00928 | 0.218 |
TRG_ER_diArg_1 | 270 | 273 | PF00400 | 0.205 |
TRG_ER_diLys_1 | 318 | 323 | PF00400 | 0.325 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3T1 | Leptomonas seymouri | 62% | 100% |
A0A0S4JM54 | Bodo saltans | 41% | 93% |
A0A1X0P9E2 | Trypanosomatidae | 45% | 100% |
A0A3Q8IQD0 | Leishmania donovani | 94% | 100% |
A0A3R7LST7 | Trypanosoma rangeli | 48% | 100% |
A4HNL9 | Leishmania braziliensis | 81% | 100% |
A4ICX5 | Leishmania infantum | 94% | 100% |
A4R8D7 | Magnaporthe oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) | 27% | 66% |
D0A2H4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 91% |
E9ASD0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
O43148 | Homo sapiens | 26% | 68% |
O74880 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 30% | 90% |
P32783 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 26% | 74% |
Q1MTD3 | Danio rerio | 30% | 81% |
Q28FT4 | Xenopus tropicalis | 25% | 80% |
Q4R7K1 | Macaca fascicularis | 26% | 68% |
Q5ADX5 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 27% | 68% |
Q5U2U7 | Rattus norvegicus | 27% | 70% |
Q61E36 | Caenorhabditis briggsae | 31% | 85% |
Q6CKI0 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | 28% | 76% |
Q6FML4 | Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) | 28% | 77% |
Q6Z9U7 | Oryza sativa subsp. japonica | 30% | 88% |
Q754U7 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 27% | 75% |
Q8SR66 | Encephalitozoon cuniculi (strain GB-M1) | 26% | 100% |
Q9D0L8 | Mus musculus | 28% | 69% |
Q9I8S2 | Xenopus laevis | 25% | 80% |
Q9LHQ7 | Arabidopsis thaliana | 30% | 87% |
Q9VJQ4 | Drosophila melanogaster | 26% | 76% |
Q9XVS1 | Caenorhabditis elegans | 29% | 85% |
V5BA31 | Trypanosoma cruzi | 46% | 100% |